Skip to main content
Clinical Trials/CTRI/2011/09/001992
CTRI/2011/09/001992
Recruiting
Phase 3

comparison of efficacy Of different treatment regimens In pulmonary artery hypertension secondary to lung disease and/or hypoxia.

Dr SK Sharma0 sites45 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Pulmonary artery hypertension secondary to lung disease and/or hypoxia
Sponsor
Dr SK Sharma
Enrollment
45
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr SK Sharma

Eligibility Criteria

Inclusion Criteria

  • ?Pulmonary artery hypertension diagnosed by doppler echocardiography as mean pulmonary artery pressure 25 mmHg (done in department of cardiology, AIIMS)
  • ?Age more than 18 years
  • ?Pulmonary artery hypertension due to hypoxia, either chronic obstructive airway disease or diffuse pulmonary lung disease
  • ?Willing to consent to participate in the trial
  • ?WHO functional class I,II, III

Exclusion Criteria

  • ?WHO functional class IV
  • ?Patient participating in any other trial
  • ?Concomitant coronary artery disease
  • ?Nitrate intake
  • ?Liver dysfunction
  • ?Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials